Active substance
Nortriptyline
- SFDA 6
- US FDA 15
- Health Canada 2
- US price lines 5
- NHS prices 5
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AVENTYL CAPSULES 10 MG | 10 mg | Capsule · Oral use | 100 Tablet Container | SAR 13.35 | NCE · Prescription | Eli Lilly and Company | Withdrawn by MAH · Not Marketed |
| AVENTYL CAPSULES 10 MG | 10 mg | Capsule · Oral use | 25 Tablet Container | SAR 3.60 | NCE · Prescription | Eli Lilly and Company | Withdrawn by MAH · Not Marketed |
| AVENTYL CAPSULES 25 MG | 25 mg | Capsule · Oral use | 100 Tablet Container | SAR 17.35 | NCE · Prescription | Eli Lilly and Company | Withdrawn by MAH · Not Marketed |
| AVENTYL CAPSULES 25 MG | 25 mg | Capsule · Oral use | 25 Tablet Container | SAR 6.30 | NCE · Prescription | Eli Lilly and Company | Withdrawn by MAH · Not Marketed |
| NORTRILEN TAB. 25 MG. | 25 mg | Tablet · Oral use | 100 Tablet Container | SAR 41.20 | Generic · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
| NORTRILEN TAB. 25 MG. | 25 mg | Tablet · Oral use | 50 Tablet Container | SAR 15.45 | Generic · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NORTRIPTYLINE HYDROCHLORIDE | EQ 75MG BASE; EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE | capsule · oral | DR REDDYS LABS SA | Prescription | 30 Mar 1992 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | TEVA | Prescription | 27 Mar 1995 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 50MG BASE; EQ 75MG BASE; EQ 25MG BASE; EQ 10MG BASE | capsule · oral | TARO | Prescription | 8 May 2000 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE/5ML | solution · oral | PHARM ASSOC | Prescription | 23 Aug 2000 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE/5ML | solution · oral | RUBICON RESEARCH | Prescription | 15 Aug 2023 |
| AVENTYL HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE | capsule · oral | LILLY | Discontinued | 6 Nov 1964 |
| AVENTYL | EQ 10MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · oral | RANBAXY | Discontinued | 6 Nov 1964 |
| PAMELOR | EQ 10MG BASE/5ML | solution · oral | SPECGX LLC | Discontinued | 1 Aug 1977 |
| PAMELOR | EQ 10MG BASE; EQ 25MG BASE; EQ 75MG BASE; EQ 50MG BASE | capsule · oral | SPECGX LLC | Discontinued | 1 Aug 1977 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | ANI PHARMS | Discontinued | 31 Dec 1992 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | RISING | Discontinued | 26 Jul 1993 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | TEVA | Discontinued | 11 Apr 1996 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | AUROBINDO PHARMA LTD | Discontinued | 30 Jun 1997 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE/5ML | solution · oral | TARO | Discontinued | 20 Jun 2006 |
| NORTRIPTYLINE HYDROCHLORIDE | EQ 10MG BASE; EQ 25MG BASE; EQ 50MG BASE; EQ 75MG BASE | capsule · oral | ZYDUS LIFESCIENCES | Discontinued | 24 Feb 2021 |
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | NORTRIPTYLINE 10 MG/5 ML SOLN | $0.26165 | per ML | 23 Sep 2026 |
| US NADAC | NORTRIPTYLINE HCL 10 MG CAP | $0.11272 | per EA | 23 Sep 2026 |
| US NADAC | NORTRIPTYLINE HCL 25 MG CAP | $0.15607 | per EA | 23 Sep 2026 |
| US NADAC | NORTRIPTYLINE HCL 50 MG CAP | $0.20739 | per EA | 23 Sep 2026 |
| US NADAC | NORTRIPTYLINE HCL 75 MG CAP | $0.27241 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Nortriptyline 10mg capsules | £14.44 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Nortriptyline 10mg tablets | £2.64 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Nortriptyline 25mg capsules | £17.50 | 100 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Nortriptyline 25mg tablets | £2.29 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Nortriptyline 50mg tablets | £55.78 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 9 Apr 2019 PAMELOR — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.